Inhibitory Effects of HangAmDan-B1 (HAD-B1) Combined With Afatinib on H1975 Lung Cancer Cell–Bearing Mice

Epidermal growth factor receptor mutation-positive non–small cell lung cancer is cared for mainly by target therapeutics in the clinical treatment at present. We investigated the antitumor effect of HangAmDan-B1 (HAD-B1) combined with afatinib on H1975 (L858R/T790M double mutation) lung cancer cells...

Descripción completa

Detalles Bibliográficos
Autores principales: Kang, Hwa Jeong, Kim, Jeehye, Cho, Seong Hyeok, Park, So-Jung, Yoo, Hwa-Seung, Kang, In-Cheol
Formato: Online Artículo Texto
Lenguaje:English
Publicado: SAGE Publications 2019
Materias:
Research Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6419252/
https://www.ncbi.nlm.nih.gov/pubmed/30866688
http://dx.doi.org/10.1177/1534735419830765

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6419252/
https://www.ncbi.nlm.nih.gov/pubmed/30866688
http://dx.doi.org/10.1177/1534735419830765

Ejemplares similares